# Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

> **NCT00030823** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 14 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine
- **BIOLOGICAL:** QS21

## Key facts

- **NCT ID:** NCT00030823
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030823, "Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00030823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*